Article

Skeletal effects of nilotinib on prepubertal and pubertal rats

Yasin I. Tayem1★, Wael A. Nasr El-Din2,3, Aisha N. Rashid2, Sindhan Veeramuthu1, Manal A. Othman2,4★ Corresponding author

  1. 1Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
  2. 2Department of Anatomy, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
  3. 3Department of Human Anatomy and Embryology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
  4. 4Department of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut, Egypt.

CORRESPONDENCE

Yasin I. Tayem

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.

yasiniyt@agu.edu.bh

Received: 22-02-2025; Accepted: 08-05-2025.

Volume 23, Issue 4 · pp. 3320 · PUBLISHED Oct-Dec 2025 · DOI: 10.18549/PharmPract.2025.4.3320

View on PP original site ↗

ABSTRACT

Background: Nilotinib belongs to a group of anti-cancer drugs called tyrosine kinase inhibitors (TKIs), which are currently the mainstay treatment of chronic myeloid leukemia (CML). Objectives: In this study, we aimed to investigate the effects of this drug on bones around puberty in vivo. Methods: Juvenile male Wistar rats were divided to three groups and were treated orally once a day. Group 1 was administered vehicle; group 2 was administered nilotinib at a low-dose (30.85 mg/kg) and group 3 was treated with a high-dose (41.13 mg/kg). The treatment continued from week 4 until week 7 of age (pre-pubertal and pubertal life). Methods: Serum calcium, insulin-like growth factor-1 (IGF-1) and procollagen type I (PINP) were measured by enzyme-linked immunosorbent assay (ELISA). Femur bone was collected for histopathological evaluation using Hematoxylin & Eosin stain, and Masson's trichrome (MTC) staining. Immunohistochemistry was performed, using the bone cellular markers antiosteopontin (OPN) and antitartrate-resistant acid phosphatase (TRAP). Results: Serum Calcium, IGF-1 and PINP declined in a dose-dependent manner (p < 0.05). Histopathological evaluation revealed dose-dependent degeneration of bone lamellae and disruption and disorganization of cellular components. Moreover, the study revealed a decrease in collagen, decrease in OPN, and increase in TRAP immunostaining. Conclusion: Nilotinib had deleterious skeletal effects around puberty, possibly requiring long-term monitoring of bone growth and mineralization.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Tayem, Y. I., El-Din, W. A. N., Rashid, A. N., Veeramuthu, S., & Othman, M. A. (2025). Skeletal effects of nilotinib on prepubertal and pubertal rats. Pharmacy Practice, 23(4), 3320. https://doi.org/10.18549/PharmPract.2025.4.3320